India
-
First floor
Report on RAI3, the dirty drug supply chain from India to Italy
On Rai3 I travel to the low-cost medicine factories where the New Delhi bacterium comes from, which has already made dozens…
Leggi » -
News
AIFA. Drugs containing ranitidine made in India withdrawn
L’Agenzia Italiana del Farmaco (AIFA) ha disposto il ritiro dalle farmacie e dalla catena distributiva di tutti i lotti di…
Leggi » -
First floor
generics. World pharmaceutical production is mostly in China and India and is a problem for Western health authorities
The historic record of drug withdrawals in Spain took place in 2018. Why? More than a hundred…
Leggi » -
News
US China trade war. The secret weapon in the hands of Beijing are medicines: they control the 40% of the active ingredients of American generic drugs
China compensates for the 40% of the active ingredients (APIs) present in American drugs and the 80% of the ingredients used by India, the first…
Leggi » -
News
Great Pharma War: India criticizes US crusade against cheap generic drugs
La spinta di Washington per i diritti di proprietà intellettuale nell’industria farmaceutica è un attacco all’industria farmaceutica indiana, secondo New…
Leggi » -
First floor
EMA recommends the suspension of 300 generics. Unreliable
EMA recommends suspension of drugs due to unreliable studies by Micro Therapeutic Research Labs The drugs in…
Leggi » -
News
Indians point to generics from Sanofi
Sanofi plans to divest Zentiva's generics business by the end of the year. The decision appeals to large Asian multinationals…
Leggi » -
News
Pharmaceuticals: only 3% of the 449 sites controlled by EU authorities in third countries were 'rejected', out of a total of 12,250. Ed
Rome, September 20. (AdnKronos Salute) – The rate of irregularities detected by the inspections of the European agencies at…
Leggi » -
News
Pharma India, the long road to regaining FDA trust. India is the largest generic producer
(Reuters Health) - Workers videotaped to ensure they follow standard procedures and 'fresh' training to the entire team if…
Leggi » -
News
Assogenerici: "Spc export exception, if 4 thousand more jobs arrive"
Rome, 22 May - Two billion euros: this is the value of the market that will originate from the patent expiries of…
Leggi »